tm logo
LYSFIO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 07 Nov 2022

Last Applicant/ Owned by

50 Binney Street

Cambridge

MA

02142

Serial Number

88330379 filed on 07th Mar 2019

Registration Number

N/A

Correspondent Address

Karen Lim

FROSS ZELNICK LEHRMAN & ZISSU, P.C.

151 WEST 42nd St., 17 Fl.

NEW YORK NY 10036

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LYSFIO

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Mark Details


Serial Number

No 88330379

Mark Type

No Service/Collective Mark

Attorney Docket Number

No GENZ 1903739

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th Nov 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
07th Nov 2022ABANDONMENT - NO USE STATEMENT FILED
25th Feb 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24th Feb 2022SOU EXTENSION 5 GRANTED
24th Feb 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
17th Feb 2022SOU EXTENSION 5 FILED
17th Feb 2022TEAS EXTENSION RECEIVED
04th Sep 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02th Sep 2021SOU EXTENSION 4 GRANTED
02th Sep 2021SOU EXTENSION 4 FILED